Model
Edge
NRX Pharmaceuticals Inc.
0001864871
Filing Type
4
Filing Date
11/28/2022
Updated
11/29/22, 12:00 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership